glomerulonephritis

Documents about glomerulonephritis

• China Glomerulonephritis Kidney Transplant Recipient Cohort: A Prospective Multicenter Observational Study#994513ClinicalTrials.gov
• Obinutuzumab in Treatment of Fibrillary Glomerulonephritis#832234ClinicalTrials.gov
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis#807949ClinicalTrials.gov
• US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis#876936ClinicalTrials.gov
• Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN#843759ClinicalTrials.gov
• Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis#885529ClinicalTrials.gov
• A Case of IgA Nephropathy With Membranoproliferative Glomerulonephritis-Like Features#194776OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.#856940ClinicalTrials.gov
• Using Renal Elastography Measurements for Evaluation of Glomerulonephritis Patients#841693ClinicalTrials.gov
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy#853576ClinicalTrials.gov
• Integrative transcriptomic and machine learning analysis identifies PYCARD and IFI30 as immune-lysosomal biomarkers of ANCA-associated glomerulonephritis.#9714PubMed
• A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)#857075ClinicalTrials.gov
• ESKD from primary glomerulonephritis: Incidence and post KRT survival: A national cohort study in the UK#141259PLOS
• PR3-ANCA associated vasculitis with rapidly progressive glomerulonephritis (RPGN): an uncommon cause of rapidly developing renal failure#361141The ESRF Research Journal for Undergraduate Medical Students
• A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial#898915ClinicalTrials.gov
• Glomerulonephritis through the lens of ultrasound and radiology.#338491NCBI PubMed Central
• Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization#907625ClinicalTrials.gov
• An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases#875409ClinicalTrials.gov
• Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study#859733ClinicalTrials.gov
• Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis#280337HAL (France)
• A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471#807239ClinicalTrials.gov
• Outcome von Patienten mit bioptisch gesicherter IgA-Nephropathie#429796Dbt
• Adrenocorticotropic Hormone in Membranous Nephropathy#878049ClinicalTrials.gov
• ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis#907085ClinicalTrials.gov
• Data Management and Sharing Plan for: Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies#260758UNC Dataverse Dataverse OAI Archive
• Supplementary Material for: Infective endocarditis-associated glomerulonephritis caused by Streptococcus cristatus: A Case Report#314650Figshare
• Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD#803024ClinicalTrials.gov
• A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy#813174ClinicalTrials.gov
• Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy#865120ClinicalTrials.gov
• Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis#883206ClinicalTrials.gov
• ESKD from primary glomerulonephritis: Incidence and post KRT survival: A national cohort study in the UK.#143016NCBI PubMed Central
• Efficacy and Safety of Atacicept in IgA Nephropathy#855252ClinicalTrials.gov
• Clinical predictors of acute kidney injury in children with acute post- streptococcal glomerulonephritis: A tertiary centre experience#249088USM Repository
• Affection of Renal and Urinary System in IBD Patients#813551ClinicalTrials.gov
• Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy#894824ClinicalTrials.gov
• Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy#267950ClinicalTrials.gov
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant#290873ClinicalTrials.gov
• Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)#833858ClinicalTrials.gov
• Tubulointerstitial inflammation in glomerular diseases: mechanistic pathways, prognostic value, and translational therapeutic targets#4515Europe PMC
• Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria#835365ClinicalTrials.gov
• Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization#18895PLOS
• Global burden and health inequalities of acute glomerulonephritis from 1990 to 2021: a systematic analysis of global burden disease study 2021#337989ScholarBank@NUS
• A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.#867035ClinicalTrials.gov
• Hospital Based Incidence of Group A Streptococcal Disease in Fiji#919097ClinicalTrials.gov
• An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis#897272ClinicalTrials.gov
• Risk prediction in IgA nephropathy: from conventional models to machine learning, deep learning, and precision nephrology.#9717PubMed
• Nudging Nephrologists in Cardiovascular Risk Assessment and Management in Glomerular Diseases Treated with Immunosuppressants: An Implementation Study#378610ScholarBank@NUS
• Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity#802582ClinicalTrials.gov
• PS-002 for the Treatment of IgA Nephropathy in Adults#895528ClinicalTrials.gov
• ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES#992349ClinicalTrials.gov